Keystone Heart is focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR.
Latest News
Share this
euro pcr

EuroPCR 2017 Symposium

Wednesday 17 May 2017
Paris, France

Protecting the Brain; While Treating the Heart
Sponsored by Keystone Heart
13:35-14:35 Room 352B

Attend this session if you want to:
• Understand the clinical need for cerebral embolic protection during cardiovascular procedures
• Learn about the clinical evidence surrounding cerebral embolic protection and the clinical experience with the TriGuard tm device
• Realise the economic impact of cerebral embolic events

13:35 Session objectives – M. Mack
13:40 New scientific guidelines NeuroARC – study – A. Lansky
13:52 Discussion and audience interaction
13:57 Keystone Heart clinical experience and evidence – R. Makkar
14:09 Discussion and audience interaction
14:14 Cost benefit analysis of cerebral embolic protection – J. Moses
14:26 Discussion and audience interaction
14:31 Session evaluation and key learnings – P. Stella

We hope to see you there!

No Comments

Leave a reply